doi:10.1016/j.bcmd.2014.06.006 [PubMed] 18
Shaw, G., Lee-Barthel, A., Ross, M
A face-to-face service where a physician or other licensed health care professional provides counseling to the patient and/or caregivers must report 90460-90461
Inject into subcutaneous tissue over the outer hip, avoiding direct injection into tender points
Although this class of drugs, called glucagon-like peptide-1 or GLP-1, have been around for more than 17 years, with the first one, Byetta, approved in 2005, it is only recently that the class has made a big name for itself with the introduction of the popular once-weekly diabetic drug, Ozempic , and the equally popular obesity drug, Wegovy (the same drug as Ozempic but with a different dose)